Brief: Century Therapeutics Reports Q2 Loss Per Share Of $1.93
12/08/2021 13:27
Aug 12 (Reuters) - Century Therapeutics Inc IPSC.O :
* CENTURY THERAPEUTICS REPORTS SECOND QUARTER 2021 FINANCIAL
RESULTS AND BUSINESS UPDATES
* CENTURY THERAPEUTICS INC QTRLY LOSS PER SHARE $1.93
* CENTURY THERAPEUTICS INC - CASH, CASH EQUIVALENTS AND
MARKETABLE
SECURITIES WERE $440.0 MILLION AS OF JUNE 30, 2021
Source text for Eikon: ID:nGNXbB07TN
Further company coverage: IPSC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Century Therapeutics
See all newsCentury Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Century Therapeutics Q2 net loss misses estimates on lease termination loss
Brief: Century Therapeutics Q2 Net Income USD -34.55 Million Vs. IBES Estimate USD -22.4 Million
Century Therapeutics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
Century Therapeutics Inc expected to post a loss of 11 cents a share - Earnings Preview